What is the projected market valuation for the Total Hip and Knee Replacements Market in 2035?

The projected market valuation for the Total Hip and Knee Replacements Market in 2035 is 37.97 USD Billion. Read More

What was the market valuation for the Total Hip and Knee Replacements Market in 2024?

The market valuation for the Total Hip and Knee Replacements Market in 2024 was 22.67 USD Billion. Read More

What is the expected CAGR for the Total Hip and Knee Replacements Market from 2025 to 2035?

The expected CAGR for the Total Hip and Knee Replacements Market during the forecast period 2025 - 2035 is 4.8%. Read More

Which companies are considered key players in the Total Hip and Knee Replacements Market?

Key players in the Total Hip and Knee Replacements Market include DePuy Synthes, Stryker, Zimmer Biomet, Smith & Nephew, Medtronic, Exactech, Aesculap, Ottobock, and B. Braun. Read More

What segment of the Total Hip and Knee Replacements Market had the highest valuation in 2024?

In 2024, the segment of Total Hip Replacement had the highest valuation at 9.5 USD Billion. Read More

What is the projected valuation for Total Knee Replacement by 2035?

The projected valuation for Total Knee Replacement by 2035 is 10.5 USD Billion. Read More

How does the valuation of Partial Hip Replacement compare to Total Hip Replacement in 2024?

In 2024, Partial Hip Replacement was valued at 3.0 USD Billion, significantly lower than Total Hip Replacement at 9.5 USD Billion. Read More

What is the expected growth for the Mobile Bearing implant type from 2025 to 2035?

The expected growth for the Mobile Bearing implant type is projected to reach 9.5 USD Billion by 2035. Read More

Which end user segment is anticipated to show the most growth in the Total Hip and Knee Replacements Market?

The Hospitals segment is anticipated to show the most growth, with a projected valuation of 14.5 USD Billion by 2035. Read More

What is the valuation range for Revision Knee Replacement in 2024?

The valuation range for Revision Knee Replacement in 2024 was between 0.5 and 1.0 USD Billion. Read More

Total Hip Knee Replacements Market

ID: MRFR/HC/10311-HCR 110 Pages Rahul Gotadki Last Updated: October 24, 2026

Total Hip and Knee Replacements Market Research Report: Information by Procedure Type (Total Hip Replacement, Partial Hip Replacement, Revision Hip Replacement, Total Knee Replacement, Partial Knee Replacement, and Revision Knee Replacement), By Implant Type (Mobile Bearing, Fixed Bearing, and Others), By End-User (Hospitals, Ambulatory Surgical Centers, Orthopedic Clinics, and Others), and Region (North America, Europe, Asia-Pacific, and Rest of the World)—Forecast till 2035

Total Hip Knee Replacements Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)4.8%

2024 Market Size$ 22.67 Billion

2025 Market Size$ 23.76 Billion

2035 Market Size$ 37.97 Billion

Key Players

DePuy Synthes

Stryker

Zimmer Biomet

Smith & Nephew

Medtronic

Exactech

Trends

Technological Advancements
Personalized Medicine
Aging Population

Opportunities

Increased Healthcare Expenditure
Growing Awareness of Joint Health
Advancements in Surgical Techniques

Summary Table of Contents Segmentation Methodology Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Healthcare, BY Procedure Type (USD Billion) | |
  1. 4.1.1 Total Hip Replacement | |
  2. 4.1.2 Partial Hip Replacement | |
  3. 4.1.3 Revision Hip Replacement | |
  4. 4.1.4 Total Knee Replacement | |
  5. 4.1.5 Partial Knee Replacement | |
  6. 4.1.6 Revision Knee Replacement |
2. 4.2 Healthcare, BY Implant Type (USD Billion) | |
  1. 4.2.1 Mobile Bearing | |
  2. 4.2.2 Fixed Bearing | |
  3. 4.2.3 Others |
3. 4.3 Healthcare, BY End User (USD Billion) | |
  1. 4.3.1 Hospitals | |
  2. 4.3.2 Ambulatory Surgical Centers | |
  3. 4.3.3 Orthopedic Clinics | |
  4. 4.3.4 Others |
4. 4.4 Healthcare, BY Region (USD Billion) | |
  1. 4.4.1 North America | | |
    1. 4.4.1.1 US | | |
    2. 4.4.1.2 Canada | |
  2. 4.4.2 Europe | | |
    1. 4.4.2.1 Germany | | |
    2. 4.4.2.2 UK | | |
    3. 4.4.2.3 France | | |
    4. 4.4.2.4 Russia | | |
    5. 4.4.2.5 Italy | | |
    6. 4.4.2.6 Spain | | |
    7. 4.4.2.7 Rest of Europe | |
  3. 4.4.3 APAC | | |
    1. 4.4.3.1 China | | |
    2. 4.4.3.2 India | | |
    3. 4.4.3.3 Japan | | |
    4. 4.4.3.4 South Korea | | |
    5. 4.4.3.5 Malaysia | | |
    6. 4.4.3.6 Thailand | | |
    7. 4.4.3.7 Indonesia | | |
    8. 4.4.3.8 Rest of APAC | |
  4. 4.4.4 South America | | |
    1. 4.4.4.1 Brazil | | |
    2. 4.4.4.2 Mexico | | |
    3. 4.4.4.3 Argentina | | |
    4. 4.4.4.4 Rest of South America | |
  5. 4.4.5 MEA | | |
    1. 4.4.5.1 GCC Countries | | |
    2. 4.4.5.2 South Africa | | |
    3. 4.4.5.3 Rest of MEA 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Healthcare | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 DePuy Synthes (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Stryker (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Zimmer Biomet (US) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Smith & Nephew (GB) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Medtronic (US) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Exactech (US) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Aesculap (DE) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Ottobock (DE) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 B. Braun (DE) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 NORTH AMERICA MARKET ANALYSIS |
6. 6.3 US MARKET ANALYSIS BY PROCEDURE TYPE |
7. 6.4 US MARKET ANALYSIS BY IMPLANT TYPE |
8. 6.5 US MARKET ANALYSIS BY END USER |
9. 6.6 CANADA MARKET ANALYSIS BY PROCEDURE TYPE |
10. 6.7 CANADA MARKET ANALYSIS BY IMPLANT TYPE |
11. 6.8 CANADA MARKET ANALYSIS BY END USER |
12. 6.9 EUROPE MARKET ANALYSIS |
13. 6.10 GERMANY MARKET ANALYSIS BY PROCEDURE TYPE |
14. 6.11 GERMANY MARKET ANALYSIS BY IMPLANT TYPE |
15. 6.12 GERMANY MARKET ANALYSIS BY END USER |
16. 6.13 UK MARKET ANALYSIS BY PROCEDURE TYPE |
17. 6.14 UK MARKET ANALYSIS BY IMPLANT TYPE |
18. 6.15 UK MARKET ANALYSIS BY END USER |
19. 6.16 FRANCE MARKET ANALYSIS BY PROCEDURE TYPE |
20. 6.17 FRANCE MARKET ANALYSIS BY IMPLANT TYPE |
21. 6.18 FRANCE MARKET ANALYSIS BY END USER |
22. 6.19 RUSSIA MARKET ANALYSIS BY PROCEDURE TYPE |
23. 6.20 RUSSIA MARKET ANALYSIS BY IMPLANT TYPE |
24. 6.21 RUSSIA MARKET ANALYSIS BY END USER |
25. 6.22 ITALY MARKET ANALYSIS BY PROCEDURE TYPE |
26. 6.23 ITALY MARKET ANALYSIS BY IMPLANT TYPE |
27. 6.24 ITALY MARKET ANALYSIS BY END USER |
28. 6.25 SPAIN MARKET ANALYSIS BY PROCEDURE TYPE |
29. 6.26 SPAIN MARKET ANALYSIS BY IMPLANT TYPE |
30. 6.27 SPAIN MARKET ANALYSIS BY END USER |
31. 6.28 REST OF EUROPE MARKET ANALYSIS BY PROCEDURE TYPE |
32. 6.29 REST OF EUROPE MARKET ANALYSIS BY IMPLANT TYPE |
33. 6.30 REST OF EUROPE MARKET ANALYSIS BY END USER |
34. 6.31 APAC MARKET ANALYSIS |
35. 6.32 CHINA MARKET ANALYSIS BY PROCEDURE TYPE |
36. 6.33 CHINA MARKET ANALYSIS BY IMPLANT TYPE |
37. 6.34 CHINA MARKET ANALYSIS BY END USER |
38. 6.35 INDIA MARKET ANALYSIS BY PROCEDURE TYPE |
39. 6.36 INDIA MARKET ANALYSIS BY IMPLANT TYPE |
40. 6.37 INDIA MARKET ANALYSIS BY END USER |
41. 6.38 JAPAN MARKET ANALYSIS BY PROCEDURE TYPE |
42. 6.39 JAPAN MARKET ANALYSIS BY IMPLANT TYPE |
43. 6.40 JAPAN MARKET ANALYSIS BY END USER |
44. 6.41 SOUTH KOREA MARKET ANALYSIS BY PROCEDURE TYPE |
45. 6.42 SOUTH KOREA MARKET ANALYSIS BY IMPLANT TYPE |
46. 6.43 SOUTH KOREA MARKET ANALYSIS BY END USER |
47. 6.44 MALAYSIA MARKET ANALYSIS BY PROCEDURE TYPE |
48. 6.45 MALAYSIA MARKET ANALYSIS BY IMPLANT TYPE |
49. 6.46 MALAYSIA MARKET ANALYSIS BY END USER |
50. 6.47 THAILAND MARKET ANALYSIS BY PROCEDURE TYPE |
51. 6.48 THAILAND MARKET ANALYSIS BY IMPLANT TYPE |
52. 6.49 THAILAND MARKET ANALYSIS BY END USER |
53. 6.50 INDONESIA MARKET ANALYSIS BY PROCEDURE TYPE |
54. 6.51 INDONESIA MARKET ANALYSIS BY IMPLANT TYPE |
55. 6.52 INDONESIA MARKET ANALYSIS BY END USER |
56. 6.53 REST OF APAC MARKET ANALYSIS BY PROCEDURE TYPE |
57. 6.54 REST OF APAC MARKET ANALYSIS BY IMPLANT TYPE |
58. 6.55 REST OF APAC MARKET ANALYSIS BY END USER |
59. 6.56 SOUTH AMERICA MARKET ANALYSIS |
60. 6.57 BRAZIL MARKET ANALYSIS BY PROCEDURE TYPE |
61. 6.58 BRAZIL MARKET ANALYSIS BY IMPLANT TYPE |
62. 6.59 BRAZIL MARKET ANALYSIS BY END USER |
63. 6.60 MEXICO MARKET ANALYSIS BY PROCEDURE TYPE |
64. 6.61 MEXICO MARKET ANALYSIS BY IMPLANT TYPE |
65. 6.62 MEXICO MARKET ANALYSIS BY END USER |
66. 6.63 ARGENTINA MARKET ANALYSIS BY PROCEDURE TYPE |
67. 6.64 ARGENTINA MARKET ANALYSIS BY IMPLANT TYPE |
68. 6.65 ARGENTINA MARKET ANALYSIS BY END USER |
69. 6.66 REST OF SOUTH AMERICA MARKET ANALYSIS BY PROCEDURE TYPE |
70. 6.67 REST OF SOUTH AMERICA MARKET ANALYSIS BY IMPLANT TYPE |
71. 6.68 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER |
72. 6.69 MEA MARKET ANALYSIS |
73. 6.70 GCC COUNTRIES MARKET ANALYSIS BY PROCEDURE TYPE |
74. 6.71 GCC COUNTRIES MARKET ANALYSIS BY IMPLANT TYPE |
75. 6.72 GCC COUNTRIES MARKET ANALYSIS BY END USER |
76. 6.73 SOUTH AFRICA MARKET ANALYSIS BY PROCEDURE TYPE |
77. 6.74 SOUTH AFRICA MARKET ANALYSIS BY IMPLANT TYPE |
78. 6.75 SOUTH AFRICA MARKET ANALYSIS BY END USER |
79. 6.76 REST OF MEA MARKET ANALYSIS BY PROCEDURE TYPE |
80. 6.77 REST OF MEA MARKET ANALYSIS BY IMPLANT TYPE |
81. 6.78 REST OF MEA MARKET ANALYSIS BY END USER |
82. 6.79 KEY BUYING CRITERIA OF HEALTHCARE |
83. 6.80 RESEARCH PROCESS OF MRFR |
84. 6.81 DRO ANALYSIS OF HEALTHCARE |
85. 6.82 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
86. 6.83 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
87. 6.84 SUPPLY / VALUE CHAIN: HEALTHCARE |
88. 6.85 HEALTHCARE, BY PROCEDURE TYPE, 2024 (% SHARE) |
89. 6.86 HEALTHCARE, BY PROCEDURE TYPE, 2024 TO 2035 (USD Billion) |
90. 6.87 HEALTHCARE, BY IMPLANT TYPE, 2024 (% SHARE) |
91. 6.88 HEALTHCARE, BY IMPLANT TYPE, 2024 TO 2035 (USD Billion) |
92. 6.89 HEALTHCARE, BY END USER, 2024 (% SHARE) |
93. 6.90 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion) |
94. 6.91 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
95. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
96. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.2.2 BY IMPLANT TYPE, 2025-2035 (USD Billion) | |
  3. 7.2.3 BY END USER, 2025-2035 (USD Billion) |
97. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.3.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.3.2 BY IMPLANT TYPE, 2025-2035 (USD Billion) | |
  3. 7.3.3 BY END USER, 2025-2035 (USD Billion) |
98. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.4.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.4.2 BY IMPLANT TYPE, 2025-2035 (USD Billion) | |
  3. 7.4.3 BY END USER, 2025-2035 (USD Billion) |
99. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.5.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.5.2 BY IMPLANT TYPE, 2025-2035 (USD Billion) | |
  3. 7.5.3 BY END USER, 2025-2035 (USD Billion) |
100. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.6.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.6.2 BY IMPLANT TYPE, 2025-2035 (USD Billion) | |
  3. 7.6.3 BY END USER, 2025-2035 (USD Billion) |
101. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.7.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.7.2 BY IMPLANT TYPE, 2025-2035 (USD Billion) | |
  3. 7.7.3 BY END USER, 2025-2035 (USD Billion) |
102. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.8.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.8.2 BY IMPLANT TYPE, 2025-2035 (USD Billion) | |
  3. 7.8.3 BY END USER, 2025-2035 (USD Billion) |
103. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.9.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.9.2 BY IMPLANT TYPE, 2025-2035 (USD Billion) | |
  3. 7.9.3 BY END USER, 2025-2035 (USD Billion) |
104. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.10.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.10.2 BY IMPLANT TYPE, 2025-2035 (USD Billion) | |
  3. 7.10.3 BY END USER, 2025-2035 (USD Billion) |
105. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.11.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.11.2 BY IMPLANT TYPE, 2025-2035 (USD Billion) | |
  3. 7.11.3 BY END USER, 2025-2035 (USD Billion) |
106. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.12.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.12.2 BY IMPLANT TYPE, 2025-2035 (USD Billion) | |
  3. 7.12.3 BY END USER, 2025-2035 (USD Billion) |
107. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.13.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.13.2 BY IMPLANT TYPE, 2025-2035 (USD Billion) | |
  3. 7.13.3 BY END USER, 2025-2035 (USD Billion) |
108. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.14.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.14.2 BY IMPLANT TYPE, 2025-2035 (USD Billion) | |
  3. 7.14.3 BY END USER, 2025-2035 (USD Billion) |
109. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.15.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.15.2 BY IMPLANT TYPE, 2025-2035 (USD Billion) | |
  3. 7.15.3 BY END USER, 2025-2035 (USD Billion) |
110. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.16.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.16.2 BY IMPLANT TYPE, 2025-2035 (USD Billion) | |
  3. 7.16.3 BY END USER, 2025-2035 (USD Billion) |
111. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.17.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.17.2 BY IMPLANT TYPE, 2025-2035 (USD Billion) | |
  3. 7.17.3 BY END USER, 2025-2035 (USD Billion) |
112. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.18.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.18.2 BY IMPLANT TYPE, 2025-2035 (USD Billion) | |
  3. 7.18.3 BY END USER, 2025-2035 (USD Billion) |
113. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.19.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.19.2 BY IMPLANT TYPE, 2025-2035 (USD Billion) | |
  3. 7.19.3 BY END USER, 2025-2035 (USD Billion) |
114. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.20.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.20.2 BY IMPLANT TYPE, 2025-2035 (USD Billion) | |
  3. 7.20.3 BY END USER, 2025-2035 (USD Billion) |
115. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.21.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.21.2 BY IMPLANT TYPE, 2025-2035 (USD Billion) | |
  3. 7.21.3 BY END USER, 2025-2035 (USD Billion) |
116. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.22.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.22.2 BY IMPLANT TYPE, 2025-2035 (USD Billion) | |
  3. 7.22.3 BY END USER, 2025-2035 (USD Billion) |
117. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.23.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.23.2 BY IMPLANT TYPE, 2025-2035 (USD Billion) | |
  3. 7.23.3 BY END USER, 2025-2035 (USD Billion) |
118. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.24.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.24.2 BY IMPLANT TYPE, 2025-2035 (USD Billion) | |
  3. 7.24.3 BY END USER, 2025-2035 (USD Billion) |
119. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.25.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.25.2 BY IMPLANT TYPE, 2025-2035 (USD Billion) | |
  3. 7.25.3 BY END USER, 2025-2035 (USD Billion) |
120. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.26.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.26.2 BY IMPLANT TYPE, 2025-2035 (USD Billion) | |
  3. 7.26.3 BY END USER, 2025-2035 (USD Billion) |
121. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.27.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.27.2 BY IMPLANT TYPE, 2025-2035 (USD Billion) | |
  3. 7.27.3 BY END USER, 2025-2035 (USD Billion) |
122. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.28.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.28.2 BY IMPLANT TYPE, 2025-2035 (USD Billion) | |
  3. 7.28.3 BY END USER, 2025-2035 (USD Billion) |
123. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.29.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.29.2 BY IMPLANT TYPE, 2025-2035 (USD Billion) | |
  3. 7.29.3 BY END USER, 2025-2035 (USD Billion) |
124. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.30.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.30.2 BY IMPLANT TYPE, 2025-2035 (USD Billion) | |
  3. 7.30.3 BY END USER, 2025-2035 (USD Billion) |
125. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.31.1 |
126. 7.32 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Enquiry

Customize Report

Total Hip Knee Replacements Market Segmentation

Total Hip Knee Replacements Market By Procedure Type (USD Billion, 2025-2035)

Total Hip Replacement
Partial Hip Replacement
Revision Hip Replacement
Total Knee Replacement
Partial Knee Replacement
Revision Knee Replacement

Total Hip Knee Replacements Market By Implant Type (USD Billion, 2025-2035)

Mobile Bearing
Fixed Bearing
Others

Total Hip Knee Replacements Market By End User (USD Billion, 2025-2035)

Hospitals
Ambulatory Surgical Centers
Orthopedic Clinics
Others

Certified Researchers

Enquiry

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”

Guilherme Gomes Martins Product Management Director

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”